Format

Send to

Choose Destination
J Proteome Res. 2006 Sep;5(9):2079-82.

Peptidomics for cancer diagnosis: present and future.

Author information

1
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada. ediamandis@mtsinai.on.ca

Abstract

Analysis of peptides in biological fluids by mass spectrometry holds promise of providing diagnostic and prognostic information for cancer and other diseases. Before this technology is used clinically, it is important to understand its advantages and limitations. These are summarized, along with proposals, on how to proceed in the future.

PMID:
16944917
DOI:
10.1021/pr060225u
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center